Sales decline 19.67% to Rs 2460.29 crore
Net loss of Glenmark Pharmaceuticals reported to Rs 351.37 crore in the quarter ended December 2023 as against net profit of Rs 272.58 crore during the previous quarter ended December 2022. Sales declined 19.67% to Rs 2460.29 crore in the quarter ended December 2023 as against Rs 3062.75 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales2460.293062.75 -20 OPM %-8.4815.48 -PBDT-297.58447.49 PL PBT-444.66295.98 PL NP-351.37272.58 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content